...I don't see the partnership with RIGL for R343 targeting asthma that was in Phase 2 either in the current [PFE] pipeline or the list of discontinued projects. It’s officially been returned to RIGL: http://finance.yahoo.com/news/Rigel-Assumes-Development-prnews-2774177046.html?x=0&.v=1